UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 35 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$24,362,721,000
-2.7%
22,825,000
+0.5%
0.02%
-10.5%
Q1 2019$25,049,869,000
+5.3%
22,722,000
-10.5%
0.02%
-9.5%
Q4 2018$23,791,038,000
-21.7%
25,400,000
+8.5%
0.02%
-8.7%
Q3 2018$30,399,407,000
+3.5%
23,400,000
+6.4%
0.02%0.0%
Q2 2018$29,380,560,000
+4.1%
22,000,000
-8.3%
0.02%
+4.5%
Q1 2018$28,210,560,000
+13.1%
24,000,000
+11.6%
0.02%
+4.8%
Q4 2017$24,943,869,000
-14.2%
21,500,000
-12.2%
0.02%
-19.2%
Q3 2017$29,077,826,000
+7.2%
24,500,000
+22.5%
0.03%0.0%
Q2 2017$27,126,199,00020,000,0000.03%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Opti Capital Management, LP 11,901$11,946,0002.07%
Context Capital Management, LLC 1,000,000$997,0000.56%
WOLVERINE ASSET MANAGEMENT LLC 33,392,000$33,442,0000.42%
SSI INVESTMENT MANAGEMENT LLC 3,000,000$2,991,0000.22%
CSS LLC/IL 2,876,000$2,883,0000.18%
PALISADE CAPITAL MANAGEMENT, LP 5,000,000$5,016,0000.15%
HBK INVESTMENTS L P 10,116,000$10,186,0000.13%
TENOR CAPITAL MANAGEMENT Co., L.P. 1,817,000$1,835,0000.11%
LINDEN ADVISORS LP 6,269,000$6,290,0000.08%
LAZARD ASSET MANAGEMENT LLC 15,000,000$15,028,0000.02%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders